-+ 0.00%
-+ 0.00%
-+ 0.00%

Innovent partner Ollin says OLN324 beats Roche’s Vabysmo on DME anatomy in Phase 1b trial

路透·03/31/2026 00:00:29

登錄查看新聞詳情